16.12.2012 Views

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION<br />

(19)<br />

INDIA (21) Application No: 120/MUMNP/2004 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application : 16/02/2004<br />

(54) Title <strong>of</strong> the invention:<br />

(51) International Classification: A 61 F 2/14 (71)<br />

(31) Priority Document No. : 60/310,227<br />

(32) Priority Date :<br />

(33) Name <strong>of</strong> priority country :<br />

(86)<br />

(43) Publication Date: <strong>24</strong>/<strong>06</strong>/<strong>2005</strong><br />

INTRA SCLERA IMPLANT FOR TREATMENT OF GLAUCOMA<br />

AND PRESBYOPIA.<br />

03/08/2001<br />

U.S.A.<br />

International Application : PCT/US02/<strong>24</strong>646<br />

No. <strong>and</strong> Filing Date : 02/08/2002<br />

(87) International :<br />

Publication No. WO03/015667 A1<br />

(61)<br />

(62)<br />

Patent <strong>of</strong> addition to<br />

Application No. : NIL<br />

Filed on N.A.<br />

Divisional to<br />

Application No. : NIL<br />

Filed on : N.A.<br />

(72)<br />

Name <strong>of</strong> the Applicant:<br />

GLAUCOMA RESEARCH<br />

TECHNOLOGIES, INC.<br />

Address <strong>of</strong> the Applicant:<br />

3111 CAMINO DEL RIO NORTH SAN<br />

DIEGO, CA 92108,<br />

A CALIFORNIA CORPORATION,<br />

UNITED STATES OF AMERICA.<br />

Name <strong>of</strong> the Inventors:<br />

CASTILLEJOS DAVID<br />

Filed U/S 5(2) before the<br />

<strong>Patents</strong> (Amendment)<br />

Ordinance,2004 : NO<br />

(57) Abstract : An intra scleral implant (10) <strong>and</strong> method <strong>of</strong> implantation for use in the treatment <strong>of</strong> intraocular pressure<br />

<strong>and</strong> presbyopia. The implant features a body portion (46) <strong>and</strong> protrusions (48) from the body portion to anchor the device<br />

in a cavity (19) formed in the scleral wall (16) <strong>of</strong> the eye(12). Optionally a drug delivery function is provided to allow<br />

long term communication <strong>of</strong> drugs to tissue surrounding the implant.<br />

( Figure: NIL )<br />

Total Pages : 17.<br />

The Patent Office Journal <strong>24</strong>.<strong>06</strong>.<strong>2005</strong> 17908

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!